Verition Fund Management
BCAB icon

Verition Fund Management’s BioAtla BCAB Stock Holding History

Verition Fund Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-844
Closed -$57.8K – 3188
2024
Q2 		$57.8K Buy
+844
New +$100K ﹤0.01% 2785
2023
Q3 		– Sell
-366
Closed -$54.9K – 2351
2023
Q2 		$54.9K Buy
+366
New +$62.9K ﹤0.01% 2032

Other funds holding BCAB

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Verition Fund Management's BCAB Position: Q3 2024 in Review

Verition Fund Management sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 844 shares — an estimated $57.8K sold.

Verition Fund Management first reported a position in BCAB in Q2 2023 and held it in 2 quarters. The position peaked at $57.8K in Q2 2024. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • Verition Fund Management reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 844 BioAtla shares in Q3 2024, an estimated $57.8K.
  • Verition Fund Management first reported a position in BioAtla in Q2 2023 and held it in 2 quarters.
  • Verition Fund Management's BioAtla position peaked at $57.8K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.